Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Finch Therapeutics Gr Q4 EPS $(1.89) Up From $(16.80) YoY

Author: Happy Mohamed | March 25, 2024 04:48pm
Finch Therapeutics Gr (NASDAQ:FNCH) reported quarterly losses of $(1.89) per share. This is a 88.75 percent increase over losses of $(16.80) per share from the same period last year.

Posted In: FNCH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist